Clin2
NCT06919640Possibly a fitEnrolling by invitation

Psilocybin and brain implant study

Chronic Pain

Treatments studied

Part of Pain clinical trials.

This trial tests whether psilocybin (the active ingredient in magic mushrooms) affects brain activity in people who already have a brain-sensing device implanted. It may help researchers understand how psilocybin works in the brain.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
20 people
Ages
21 years to 75 years
Study type
Interventional

Who can take part

  • You already have a brain-sensing device like RC+S or Percept implanted
  • You are not in any other research study
  • You can speak and read English
  • You can attend all study visits (in-person and by video)
  • You agree not to change your medications or have major surgery during the trial
  • You have someone to take you home after the psilocybin session or a study team member can accompany you

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06518720Recruiting· Phase 2
Psilocybin for Chronic Nerve Pain and Depression

This trial tests whether psilocybin (a psychedelic medication) can help people who have both chronic nerve pain and depression that hasn't responded to standard treatments. The goal is to see if it can reduce pain and improve mood.

Toronto, Ontario
NCT06731335Recruiting· Phase 2
Psilocybin for chronic nerve pain that hasn't improved with other treatments

This study tests whether psilocybin (a compound found in certain mushrooms) can help reduce chronic nerve pain that has not responded well to standard medications. You will receive study treatment plus psychotherapy to see if it improves your pain.

Toronto, Ontario
NCT07079852Not yet recruiting· Phase 1/Phase 2
Psilocybin and its effects on memory and brain function

This trial tests how psilocybin, a psychedelic substance, affects your thinking, memory, and brain activity. Researchers want to understand these effects in healthy adults who have used psychedelics before.

Austin, Texas
NCT07306364Not yet recruiting· Phase 2
Psilocybin plus physical therapy for chronic low back pain

This study tests whether a single dose of psilocybin (the active ingredient in 'magic mushrooms') combined with physical therapy can help relieve chronic low back pain. It aims to see if this approach can reduce pain and improve your ability to do daily activities.

New Haven, Connecticut
NCT06827054Not yet recruiting· Phase 2
Psilocybin therapy for chronic cancer pain

This trial tests if a single dose of psilocybin (a psychedelic drug from certain mushrooms) given with psychological support can help reduce long-term pain in people with cancer who are already taking opioid painkillers.

Buffalo, New York
NCT06355414Recruiting· Phase 1
Psilocybin for chronic back pain and depression

This trial tests if psilocybin, a psychedelic drug, can help people with long-term low back pain who also have depression. If you qualify, you'll receive psilocybin in a controlled setting, and researchers will see how it affects your pain and mood.

Baltimore, Maryland

Hear when a new Chronic pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.